While there are many factors that contribute to the development and progression of AD, a hallmark sign is the brain’s inability to properly metabolize glucose, the primary source of food for the brain. Axona is a clinically tested therapy for AD available in an easy-to-mix, once daily prescription drink and is the only therapy available that focuses on replenishing brain cells affected by AD. Axon
a works by providing a predictable level of ketone bodies, natural compounds that the brain can use as an alternative energy source, when glucose is compromised. While the current medications on the market (i.e., Aricept, Namenda, Exelon, etc.) are effective, they do not address the issue of starved brain cells, which has been shown to significantly impact the severity of the disease. Additionally, Axona can be taken in conjunction with a patient's current AD medications, ultimately addressing the disease from multiple angles. Visit www.about-axona.com to learn more about the role of glucose metabolism in AD and how Axona may be able to improve cognitive function in some individuals.
